Changes in the Electrocardiogram of Cancer Patients Receiving 5-Flurouracil Chemotherapy
Received: 03-Dec-2022 / Manuscript No. roa-22-83867 / Editor assigned: 05-Dec-2022 / PreQC No. roa-22-83867 (PQ) / Reviewed: 19-Dec-2022 / QC No. roa-22-83867 / Revised: 23-Dec-2022 / Manuscript No. roa-22-83867 (R) / Published Date: 30-Dec-2022 DOI: 10.4172/2167-7964.1000417
Image Article
At the national Cancer Institute-University of Gezira, a prospective cross-sectional and analytical hospital-based study was carried out to evaluate the electrocardiogram changes of cancer patients who received 5-fluorouracil chemotherapy from September to December 2018. This study included 100 patients who had been diagnosed with cancer and were receiving 5FU-based chemotherapy. The patient’s most personal information and other medically relevant information were included in a structured questionnaire that was developed, and the questionnaire’s notes were reviewed.
A cardiologist then interpreted the 12-lead ECGs that were recorded before and 24 hours after the beginning of the chemotherapy treatment for 5FU. 29% of patients’ ECG records changed after 5 FU, according to the study. The pattern of ECG changes was left axis deviation in 4 percent of the patents. 5 percent have right bundle branch block, 3 percent have an inverted T wave, 5 percent have a corrected QT interval between 0.471 and 0.50 seconds, 3 percent have a QT interval greater than 0.50 seconds, 2 percent have left ventricular hypertrophy, and 7 percent have a low voltage compared to normal ECG records prior to taking 5FU. However, neither the rhythm nor the ST segment is altered in the study [1,2].
Additionally, the study discovered that there was no correlation between the drug’s mode of administration and ECG changes. After the treatment, there was a correlation between the number of cycles and heart rate, and there was a significant correlation between the number of cycles and T wave inversion. The study concludes that electrocardiogram changes caused by 5-fluorouracil chemotherapy are a sign of cardio toxicity (Figure 1).
Figure 1: Result of chest x-ray and electrocardiogram.
Acknowledgement
None
Conflict of Interest
None
References
- Ensley JF, Patel B, Kloner R, Kish JA, Wynne J, et al. (1989) The clinical syndrome of 5-fluorouracil cardiotoxicity. Invest New Drugs7: 101-109.
- Millward MJ, Ganju V, Buck M (1988) Cardiac arrest- -a manifestation of 5-fluorouracil cardiotoxicity. Aust N Z J Med 18: 693-695.
Indexed at, Google Scholar, Crossref
Citation: Gupta S (2022) Changes in the Electrocardiogram of Cancer Patients Receiving 5-Flurouracil Chemotherapy. OMICS J Radiol 11: 417. DOI: 10.4172/2167-7964.1000417
Copyright: © 2022 Gupta S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 589
- [From(publication date): 0-2022 - Jul 18, 2024]
- Breakdown by view type
- HTML page views: 450
- PDF downloads: 139
